World Safety Biomarkers Summit March 29, 2011

The World Safety Biomarkers Summit is designed to bring together industry leaders, clinicians and academics to engage in discussion on the practical and regulatory challenges relating to safety biomarker development. The summit aims to discuss topics including translating safety biomarkers from preclinical studies into clinical development, addressing the regulatory barriers for safety biomarker qualification, how drug developers are identifying and validating organ-specific biomarkers, improving our understanding of the role of genomic technologies in safety biomarker identification, how to enhance collaboration between pharma industry, clinicians and academics to drive forward safety biomarker development.

Rakesh Dixit will present on "Challenges to Assessment of Safety Biomarkers for Biologics."

MedImmune is a sponsor.